We are live on ! Find out more
APVO icon

Aptevo Therapeutics

hedge funds and large institutions have $37.7M invested in Aptevo Therapeutics in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more capital invested

Capital invested by funds: $37.4M → $37.7M (+$303K)

Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Barclays
26
Barclays
United Kingdom
$105K
Bank of New York Mellon
27
Bank of New York Mellon
New York
$96K
Arrowstreet Capital
28
Arrowstreet Capital
Massachusetts
$93K
PAM
29
Panagora Asset Management
Massachusetts
$89K
Axa
30
Axa
France
$71K
Millennium Management
31
Millennium Management
New York
$70K
Macquarie Group
32
Macquarie Group
Australia
$69K
State Street
33
State Street
Massachusetts
$62K
OAC
34
OMERS Administration Corp
Ontario, Canada
$60K
RC
35
RBF Capital
California
$56K
SWA
36
SFMG Wealth Advisors
Texas
$56K
SEI Investments
37
SEI Investments
Pennsylvania
$54K
PPA
38
Parametric Portfolio Associates
Washington
$52K
PA
39
Parallel Advisors
California
$41K
Russell Investments Group
40
Russell Investments Group
United Kingdom
$37K
TRSOTSOK
41
Teachers Retirement System of the State of Kentucky
Kentucky
$28K
Morgan Stanley
42
Morgan Stanley
New York
$21K
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$17K
PNC Financial Services Group
44
PNC Financial Services Group
Pennsylvania
$10K
WSTAM
45
Wilbanks Smith & Thomas Asset Management
Virginia
$6K
Fidelity Investments
46
Fidelity Investments
Massachusetts
$3K
US Bancorp
47
US Bancorp
Minnesota
$2K
Wells Fargo
48
Wells Fargo
California
$2K
EARNEST Partners
49
EARNEST Partners
Georgia
$1K
HR
50
Howe & Rusling
New York
$1K